Skip to main content

Day: September 11, 2023

Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration

Acquisition Expands Operations in Mississippi, Texas and Louisiana CINCINNATI, Sept. 11, 2023 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has acquired a business with operations in Mississippi, Texas and Louisiana reporting unaudited annual revenues (12 months ending June 30, 2023) of approximately $9 million ‎with anticipated Adjusted EBITDA (defined below) of $2 million post integration. As a reminder all financial figures stated are in USD. Acquisition Details The acquisition adds scale with ten locations across three states, 17,500 active patients, 1,900 unique referring physicians, important insurance contracts, and decades of operating experience in the...

Continue reading

FuelCell Energy Reports Third Quarter of Fiscal 2023 Results

Third Quarter Fiscal 2023 Financial Highlights(All comparisons are year-over-year unless otherwise noted)Revenues of $25.5 million compared to $43.1 million Gross loss of $(8.2) million compared to $(4.2) million Loss from operations of $(41.4) million compared to $(28.0) million Net loss per share was $(0.06) compared to $(0.08)DANBURY, Conn., Sept. 11, 2023 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) — a global leader in decarbonizing power and producing hydrogen through its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy — today reported financial results for its third quarter ended July 31, 2023. “For the third quarter of fiscal year 2023, reported revenues were down versus the comparable prior year quarter. This was primarily a result of lower product...

Continue reading

NaaS Technology Records 132% YoY Revenue Growth in H1 2023, Offline and Innovative Services Stands Unprecedented 53.4% of Revenue

Beijing, China, Sept. 11, 2023 (GLOBE NEWSWIRE) — The year 2023 has undeniably brought economic recession on a global scale, where market volatility has become the norm, casting a shadow over numerous industries. However, against this backdrop of uncertainty, several brokerages have singled out the new energy sector as a beacon of investment potential for the year, making it a central focus of their endeavors.  This sentiment gains support from the quarterly and interim financial results unveiled on September 8th, by NaaS Technology Inc. (NASDAQ: NAAS), a leading EV charging service provider, as well as the first U.S. listed EV charging service company in China. Despite prevailing economic challenges and the ongoing transformation hurdles that loom over the new energy industry, NaaS, though, displays notable resilience. NaaS...

Continue reading

Red Cat Holdings Announces Record Revenue for First Quarter of Fiscal 2024 and Provides Revenue Guidance for Fiscal Second and Third Quarters

Strong business outlook and visibility supported by current purchase orders SAN JUAN, Puerto Rico, Sept. 11, 2023 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announces revenue for the first quarter of fiscal 2024 (three months ending July 30, 2023) ahead of its quarterly filing and provides revenue guidance for the second and third quarters of fiscal 2024. Revenue in the fiscal first quarter for the three months ending July 30, 2023 was $1.75 million. This revenue is entirely from the Company’s Enterprise Division and specifically from its Teal Drones (“Teal”) subsidiary that sells drones predominantly to the military and other public agencies. Given...

Continue reading

Cellectar Biosciences Announces Closing of up to Approximately $103 Million Private Placement Financing

FLORHAM PARK, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced that it has closed on its previously announced private placement with certain institutional investors that is expected to result in gross proceeds of up to $102.9 million, including gross proceeds of $24.5 million which the Company received at closing. The financing was led by Rosalind Advisors with participation from AIGH Capital, ADAR1, Second Line, Nantahala Capital, AuGC, and other new and existing institutional investors. Pursuant to the securities purchase agreement, Cellectar issued to purchasers (i) an aggregate $24.5 million in shares of the Company’s...

Continue reading

Sintana Energy Inc. Provides Update on Upcoming Communications and Investor Relations Initiatives

TORONTO, Sept. 11, 2023 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSX-V: SEI) (“Sintana” or the “Company”) is pleased to provide the following update regarding certain upcoming communications and investor relations initiatives. Pareto Securities 30th Annual Energy Conference Sintana will be participating in Pareto Securities’ 30th annual Energy Conference taking place on September 20th and 21st in Oslo. It is one of Europe’s largest and highest profile energy conferences. In 2022, the conference brought together over 1,800 participants from across industry including investors, operators and other stakeholders. Sintana will make a corporate presentation on September 20th, in addition to meeting individually with investors. Engagement of Auctus Advisors LLP Further, Sintana is pleased to announce the engagement of Auctus...

Continue reading

Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 

Initial primary endpoint data anticipated in late 2023 or early Q1 2024 WALTHAM, Mass., Sept. 11, 2023 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that the first participant has been dosed in the CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life extended monoclonal antibody, for the prevention of symptomatic COVID-19. This clinical trial is designed to rapidly generate the clinical data needed to support a potential emergency use authorization (EUA) submission for VYD222. CANOPY is expected to enroll approximately 750 participants in two cohorts (A and B) including 300 individuals who are significantly immunocompromised. “The initiation of the CANOPY pivotal...

Continue reading

Telesat and SpaceX Announce 14-Launch Agreement for Advanced Telesat Lightspeed LEO Satellites

OTTAWA and HAWTHORNE, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, and SpaceX, which designs, manufactures and launches the world’s most advanced rockets and spacecraft, today announced a multi-launch agreement to deliver the Telesat Lightspeed constellation to Low Earth Orbit (LEO). Telesat has contracted 14 launches on SpaceX’s Falcon 9, the most reliable and only reusable orbital rocket flying today, which will carry up to 18 Telesat Lightspeed satellites to LEO per launch. The launch campaign is scheduled to commence in 2026 and will take advantage of SpaceX’s high launch cadence to rapidly deploy the satellites and enable Telesat to begin providing global service in 2027. Launches for the campaign will lift off from SpaceX’s launch...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.